Researchers at Winship Cancer Institute of Emory University have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a...
Vous n'êtes pas connecté
Immune checkpoint blockade (ICB) is one of the primary methods of tumour immunotherapy. It involves reactivating the immune system, which cancer has turned off, in order to target and destroy cancer cells more effectively. However, clinical data have shown that only a portion of patients respond to ICB treatment. Since the tumour’s immune-suppressive environment plays a crucial [...]
Researchers at Winship Cancer Institute of Emory University have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a...
Researchers at Winship Cancer Institute of Emory University have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a...
New study reveals how ovarian cancer shields itself from the immune system, opening doors to innovative immunotherapy methods for more effective...
Researchers from The University of Texas MD Anderson Cancer Centre, USA, demonstrated that anti-PD-L1 immunotherapy in combination with...
Despite significant advancements in cancer treatment, drug resistance remains a persistent challenge. Cancer cells can often develop resistance to...
Blood stem cells contribute to maintaining the age-related imbalance of the two main types of immune cells innate and adaptive. Effective immune...
Unlike most cells in the human body, stem cells have the unique ability to divide indefinitely. This unique property makes them especially appealing...
In a breakthrough study published in Cell Reports, researchers from Professor Idit Shachar’s laboratory at the Weizmann Institute of Science have...
Scientists have created a 3D-printed model to mimic the specific conditions that spur the spread of cancer cells. The model, published in the...
Chloride ion flows that enter the cells play an important role in the duplication of glioblastoma cells, a highly aggressive brain tumour. This is the...